Rice Hall James & Associates, LLC Nektar Therapeutics Transaction History

Rice Hall James & Associates, LLC

$1.54 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$13.07 - $18.84 $6.46 Million - $9.32 Million	-494,568 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$16.52 - $20.4 $1.18 Million - $1.46 Million	-71,514 Reduced 12.63%	494,568 $8.49 Million
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $38,038 - $58,481	-2,297 Reduced 0.4%	566,082 $11.3 Million
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $387,169 - $467,205	-24,551 Reduced 4.14%	568,379 $9.66 Million
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $449,539 - $671,734	27,097 Added 4.79%	592,930 $9.84 Million
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $298,287 - $414,700	-17,692 Reduced 3.03%	565,833 $13.1 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $193,941 - $374,747	-13,403 Reduced 2.25%	583,525 $10.4 Million
Q4 2019 Jan 29, 2020	SELL	$15.87 - $23.12 $329,239 - $479,647	-20,746 Reduced 3.36%	596,928 $12.9 Million
Q3 2019 Oct 30, 2019	SELL	$16.91 - $36.27 $208,415 - $447,027	-12,325 Reduced 1.96%	617,674 $11.3 Million
Q2 2019 Aug 01, 2019	SELL	$31.0 - $36.3 $1.25 Million - $1.47 Million	-40,360 Reduced 6.02%	629,999 $22.4 Million
Q1 2019 May 01, 2019	BUY	$31.58 - $46.35 $674,454 - $989,896	21,357 Added 3.29%	670,359 $22.5 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $5.93 Million - $11 Million	194,970 Added 42.94%	649,002 $21.3 Million
Q3 2018 Oct 25, 2018	SELL	$46.46 - $68.49 $504,137 - $743,184	-10,851 Reduced 2.33%	454,032 $27.7 Million
Q2 2018 Aug 02, 2018	BUY	$46.25 - $104.45 $179,912 - $406,310	3,890 Added 0.84%	464,883 $22.7 Million
Q1 2018 Apr 25, 2018	SELL	$57.4 - $108.44 $32.6 Million - $61.6 Million	-568,339 Reduced 55.21%	460,993 $49 Million
Q4 2017 Jan 23, 2018	SELL	$23.02 - $60.5 $4.79 Million - $12.6 Million	-207,977 Reduced 16.81%	1,029,332 $61.5 Million
Q3 2017 Oct 30, 2017	BUY	$17.79 - $24.0 $22 Million - $29.7 Million	1,237,309	1,237,309 $29.7 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account